Evaluation of Liver Disease in Pregnancy

Gres Karim; Dewan Giri; Tatyana Kushner; Nancy Reau

doi:10.1016/j.cld.2022.08.009

Evaluation of Liver Disease in Pregnancy

Clin Liver Dis. 2023 Feb;27(1):133-155. doi: 10.1016/j.cld.2022.08.009. Epub 2022 Oct 18.

Authors

Gres Karim¹, Dewan Giri¹, Tatyana Kushner², Nancy Reau³

Affiliations

¹ Department of Medicine, Mount Sinai Beth Israel, 350 East 17th Street, 20th Floor, New York, NY 10003, USA.
² Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, Box 1123, New York, NY 10023, USA; Department of Obstetrics, Gynecology, and Reproductive Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, Box 1123, New York, NY 10023, USA. Electronic address: Tatyana.kushner@mssm.edu.
³ Division of Hepatology, Rush University Medical Center, 1725 West Harrison Street | Suite 319, Chicago, IL 60612, USA.

PMID: 36400462
DOI: 10.1016/j.cld.2022.08.009

Abstract

Liver disease in pregnancy often requires diagnostic and therapeutic considerations that are unique to pregnancy. Liver disease in pregnancy is commonly thought of as either liver disease unique to pregnancy, chronic liver disease, or liver disease coincidental to pregnancy. This review summarizes the approach to evaluation of liver disease in pregnancy.

Keywords: HELLP; Hyperemesis gravidarum; Intrahepatic cholestasis of pregnancy; Nonalcoholic fatty liver disease; Preeclampsia; Pregnancy.

Publication types

Review

MeSH terms

Female
Humans
Liver Diseases* / diagnosis
Liver Diseases* / therapy
Pregnancy
Pregnancy Complications* / diagnosis
Pregnancy Complications* / therapy